CS MEDICA A/S (“CS MEDICA” or the “Company”) announces today that the CEO of the Company, Lone Henriksen, has acquired 10 470 shares in CS MEDICA through several transactions at an average price of 7,33 DKK, amounting to a total value of 76 779,76 DKK.

CEO of CS MEDICA, Lone Henriksen, has purchased 10 470 shares in the open market at an average price of 7,33 DKK per share, corresponding to a total purchase of 76 779,76 DKK. The transactions have been disclosed to the Danish financial supervisory register. Following the transaction, Lone owns 4 065 441 CS MEDICA shares.

For more information about CS MEDICA, please contact:
Lone Henriksen, CEO
Phone: + (45) 71 20 30 47
Email: lh@galaxapharma.com
Website: https://www.cs-medica.com/

CS MEDICA A/S is a Danish medico cannabis company founded in 2011. CS MEDICA is committed to developing, manufacturing, and commercializing over-the-counter (OTC) medical device products containing cannabinoids. The Company runs its business through the two fully-owned subsidiaries, Galaxa Pharma A/S (distributor and representative of foreign manufacturers in the Nordic, registered medical device product distributor) and CanNordic A/S (Medical device developer and seller (BtB), registered medical device product manufacturer). CS MEDICA distributes products across the European borders and is headquartered in Copenhagen, Denmark.

The company is listed on Spotlight Stock Market in Stockholm (symbol: “CSMED”). For more information about CS MEDICA cs-medica.com.

Tags: